Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 21% ± 6% | |
intestine | 10 studies | 30% ± 12% | |
kidney | 9 studies | 31% ± 17% | |
lung | 8 studies | 27% ± 10% | |
brain | 7 studies | 34% ± 14% | |
liver | 6 studies | 25% ± 15% | |
eye | 5 studies | 22% ± 5% | |
pancreas | 3 studies | 40% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4647.84 | 1445 / 1445 | 100% | 48.27 | 183 / 183 |
kidney | 100% | 16708.31 | 89 / 89 | 100% | 84.26 | 901 / 901 |
liver | 100% | 5108.59 | 226 / 226 | 100% | 78.97 | 406 / 406 |
ovary | 100% | 2992.79 | 180 / 180 | 100% | 64.06 | 430 / 430 |
pancreas | 100% | 3189.70 | 328 / 328 | 100% | 51.00 | 178 / 178 |
stomach | 100% | 4473.64 | 359 / 359 | 100% | 79.35 | 286 / 286 |
uterus | 100% | 3305.65 | 170 / 170 | 100% | 70.93 | 459 / 459 |
breast | 100% | 5025.48 | 459 / 459 | 100% | 63.18 | 1117 / 1118 |
thymus | 100% | 5329.78 | 653 / 653 | 100% | 77.62 | 604 / 605 |
intestine | 100% | 6984.66 | 966 / 966 | 100% | 93.62 | 526 / 527 |
prostate | 100% | 3512.82 | 245 / 245 | 100% | 61.46 | 501 / 502 |
skin | 100% | 4021.84 | 1809 / 1809 | 100% | 61.91 | 471 / 472 |
brain | 100% | 3560.64 | 2632 / 2642 | 100% | 71.10 | 705 / 705 |
adrenal gland | 100% | 5058.59 | 258 / 258 | 100% | 59.94 | 229 / 230 |
lung | 99% | 3096.10 | 575 / 578 | 100% | 56.47 | 1155 / 1155 |
bladder | 100% | 4876.52 | 21 / 21 | 99% | 72.51 | 501 / 504 |
adipose | 100% | 5126.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 91.79 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.57 | 29 / 29 |
muscle | 100% | 7212.81 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3124.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.58 | 1 / 1 |
blood vessel | 100% | 2924.24 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 9567.31 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 2604.48 | 836 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901289 | Biological process | succinyl-CoA catabolic process |
GO_0006099 | Biological process | tricarboxylic acid cycle |
GO_0045244 | Cellular component | succinate-CoA ligase complex (GDP-forming) |
GO_0005739 | Cellular component | mitochondrion |
GO_0009361 | Cellular component | succinate-CoA ligase complex (ADP-forming) |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004776 | Molecular function | succinate-CoA ligase (GDP-forming) activity |
GO_0004775 | Molecular function | succinate-CoA ligase (ADP-forming) activity |
GO_0005515 | Molecular function | protein binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SUCLG1 |
Protein name | Succinate-CoA ligase GDP/ADP-forming subunit alpha Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) |
Synonyms | tmp_locus_1 |
Description | FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. . FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. . FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. . FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and specificity for either ATP or GTP is provided by different beta subunits. . |
Accessions | A0A494C0D1 B2R8A1 H7C233 P53597 ENST00000651342.1 A8K4W7 ENST00000393868.7 Q6IAL5 ENST00000442240.5 |